Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives.


Gastrointestinal bleeding (GIB) is a potentially fatal and avoidable medical condition that poses a burden on global health care costs. The rate of major GIB related to the use of some direct acting oral anticoagulant drugs (DOACs), is higher than that detected in warfarin users. Current strategies in the treatment of GIBs in patients receiving warfarin or… (More)
DOI: 10.1016/j.thromres.2015.10.016

4 Figures and Tables


  • Blog articles referencing this paper

  • Presentations referencing similar topics